학술논문
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs
Document Type
Article
Author
Source
In: Tumori . (Tumori, 2024)
Subject
Language
English
ISSN
20382529
03008916
03008916